Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

N-Arachidonoyl-L-serine (CAS 187224-29-9)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine
Application:
N-Arachidonoyl-L-serine is an endocannabinoid-like compound and CB1/CB2 agonist
CAS Number:
187224-29-9
Purity:
≥98%
Molecular Weight:
391.54
Molecular Formula:
C23H37NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Endocannabinoid-like brain constituent with similar biological profile like abnormal cannabidiol. Binds weakly to CB1 and CB2 receptors and TRPV1. Produces endothelium-dependent vasodilation. Increases phosphorylation of Akt and mitogen-activated protein.


N-Arachidonoyl-L-serine (CAS 187224-29-9) References

  1. N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.  |  Milman, G., et al. 2006. Proc Natl Acad Sci U S A. 103: 2428-33. PMID: 16467152
  2. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.  |  McHugh, D., et al. 2008. Mol Pharmacol. 73: 441-50. PMID: 17965195
  3. Nitric oxide synthase inhibition promotes endothelium-dependent vasodilatation and the antihypertensive effect of L-serine.  |  Mishra, RC., et al. 2008. Hypertension. 51: 791-6. PMID: 18212272
  4. N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons.  |  Guo, J., et al. 2008. J Neurophysiol. 100: 1147-51. PMID: 18234973
  5. The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels.  |  Godlewski, G., et al. 2009. J Pharmacol Exp Ther. 328: 351-61. PMID: 18923087
  6. Receptors for acylethanolamides-GPR55 and GPR119.  |  Godlewski, G., et al. 2009. Prostaglandins Other Lipid Mediat. 89: 105-11. PMID: 19615459
  7. N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis.  |  Cohen-Yeshurun, A., et al. 2011. J Cereb Blood Flow Metab. 31: 1768-77. PMID: 21505478
  8. Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids.  |  Yévenes, GE. and Zeilhofer, HU. 2011. PLoS One. 6: e23886. PMID: 21901142
  9. N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury.  |  Cohen-Yeshurun, A., et al. 2013. J Cereb Blood Flow Metab. 33: 1242-50. PMID: 23695434
  10. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.  |  Cazade, M., et al. 2014. Mol Pharmacol. 85: 218-25. PMID: 24214826
  11. Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury.  |  Mann, A., et al. 2015. J Neuroimmune Pharmacol. 10: 356-63. PMID: 25721934
  12. Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium.  |  Kino, T., et al. 2016. Biochem Biophys Rep. 8: 254-260. PMID: 28955964
  13. N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential.  |  Burstein, SH. 2018. Mol Pharmacol. 93: 228-238. PMID: 29138268
  14. Combining endocannabinoids with retigabine for enhanced M-channel effect and improved KV7 subtype selectivity.  |  Larsson, JE., et al. 2020. J Gen Physiol. 152: PMID: 32365171
  15. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.  |  Chester, LA., et al. 2022. Cannabis Cannabinoid Res.. PMID: 36493386

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

N-Arachidonoyl-L-serine, 10 mg

sc-202718
10 mg
$230.00